Zacks Small Cap Research on MSN
MTVA: Positive results for 48 mg cohort in phase 1b trial of DA-1726
By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results